It has been reported that an increased number of tumor-infiltrating TCs is associated with increased neoantigen production and the expression of programmed death receptor-1 (PD-1) and its ligand, PD-L1, a target of immune checkpoint blockade, in POLEmut and MSI tumors [16,18,20,28]. Here, CD274 is linked to neoplasm.